Depressive disorders Flashcards

1
Q

Etiology for MDD - inherited factors

A
  • First-degree relatives of patients with MDD have a 2-4x higher risk of MDD than the general population
  • Patients with mood disorders also have an increased familial incidence of substance abuse.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for MDD

A
  • History of prior episode of depression
  • Family history of depressive disorder especially in first degree relatives
  • History of suicide attempts
  • Postpartum period (especially first 4 weeks)
  • Comorbid medical illness
  • Absence of social support
  • Negative, stressful life events
  • Active substance abuse
  • Female gender
  • Neuroticism
  • Adverse childhood experiences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sleep disturbances in depression

A
  • delayed sleep onset
  • decreased sleep continuity with more awakenings
  • decreased REM latency (time between falling asleep and first REM period)
  • longer first REM period
  • abnormal delta wave sleep (slow wave)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MDD - epidemiology

A
  • 12-month prevalence of MDD in the U.S. = 7%
  • Significant differences by age group – much more prominent in the 20s vs. 60s
  • No ethnic differences in prevalence
  • Rates of MDD in women are 1.5 - 3x higher than rates in men.
  • Women typically experience sadness, worthlessness, and excessive guilt
  • Men typically experience fatigue, irritability, anhedonia, and insomnia
  • Higher incidence of MDD in separated or divorced people than in married individuals, especially men.
  • Medically ill patients have a greater incidence of depression.
  • Depression is associated with greater use of general health services.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnosis of MDD

A

5 or more of the following symptoms, present most of the day, nearly every day, during the same 2-week period.

At least one of the symptoms is either:

(1) depressed mood, or
(2) loss of interest or pleasure

  • Depressed mood most of the day
  • Markedly decreased interest or pleasure
  • Significant weight loss (or gain)
  • Insomnia or hypersomnia
  • Psychomotor retardation or agitation
  • Fatigue or loss of energy
  • Feelings of worthlessness or excessive guilt
  • Diminished ability to think or concentrate or - indecisiveness
  • Recurrent thoughts of death
  • The symptoms cause marked distress or impairment.
  • The symptoms are not due to the direct physiological effects of a substance.
  • The occurrence is not better explained by schizoaffective disorder, schizophrenia, schizophreniform disorder, delusional disorder, or other specified and unspecified schizophrenia spectrum and other psychotic disorders.
  • There has never been an episode of mania or hypomania.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Development and course of MDD

A
  • Remission = 2 mon without qualifying sxs, or with only 1-2 sxs present to a mild degree
  • 50% of patients experience a recurrence of MDE after their initial presentation
  • Each new episode increases the risk for future recurrence
  • Each recurrent episode is typically more severe and with more abrupt onset.
  • The longer sxs are present, the harder they are to treat!
  • Chance of remission is about 50% after 6 months of symptoms
  • If symptoms persist to longer than 2 years, chance of remission is less than 5%

Greater chance of recurrent MDE if…

  • Severe sxs in most recent episode
  • Inadequate treatment
  • Discontinuation of effective tx
  • Young age
  • Persistence of mild depressive sxs during remission
  • Multiple previous episodes of depression
  • High expressed emotion in the family
  • Martial problems
  • Psychotic sxs, prominent anxiety, co-morbid - personality disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prognosis of MDD

A

Good prognostic indicators

  • Mild sxs
  • No psychosis
  • Advanced age at onset
  • No co-morbid psychiatric disorders
  • Good social functioning for ~5 yrs before sx onset
  • History of solid friendships during adolescence

Many bipolar illnesses begin with a depressive episode, so there’s a chance that your MDD patient actually has bipolar disorder but just hasn’t been manic yet!

BPAD is especially likely if:

  • Depressive episode dx in adolescence
  • Psychotic features present
  • Family history of BPAD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Suicide in MDD

A
  • The lifetime risk of suicide in mood disorders is 10-20%.
  • The risk of attempted suicide is increased 41 times compared to people with other diagnoses.
  • 80% of people who commit suicide have a mood disorder.
  • Women attempt suicide more frequently than men, but men are more likely to die in the attempt because they tend to use more violent methods.
  • As many as 4% of people who commit suicide murder someone else first.
  • 10% of people who attempt suicide will eventually kill themselves.
  • Suicidality is the feature of depressive disorder that poses substantial risk of mortality in the disorder.
  • Prevention of suicide – more than any other goal, requires immediate intervention and may require hospitalization.
  • The risk for subsequent completed suicide for an individual hospitalized for an episode of severe MDD is about 15%.
  • Suicide is the #1 reason for malpractice suits against psychiatrists.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Factors suggesting an increased risk for suicide

A

Demographics

  • male
  • recent personal loss
  • single, widowed, or divorced
  • older age
  • caucasian

Symptoms

  • severe depression
  • anxiety
  • hopelessness
  • psychosis, especially with command hallucinations

Suicidal thinking

  • specific plan
  • means to carry out the plan
  • absence of protective factors
  • rehearsal of the plan
  • high lethality of method

History

  • previous attempts, especially if many or severe
  • family history of suicide
  • active substance abuse
  • previous psychiatric hospitalization for any reason
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Protective factors against suicide

A
  • Involvement of children or pets
  • Support from loved ones, responsibility to family
  • Religious prohibition
  • Optimism about future
  • Previous response to treatment
  • Patient contracts for safety*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Other depressive disorders

A
  • Depressive disorders caused by medical illnesses are not considered to be primary depressive disorders –> The diagnosis is Depressive disorder due to another medical condition.
  • Depressive disorders caused by medications or psychoactive substances are not considered to be primary depressive disorders either –> The diagnosis is Substance/Medication-induced depressive disorder.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnosis of Persistent Depressive Disorder

A

Depressed mood for most of the day for at least 2 years

Presence while depressed, of two or more of the following

  • Poor appetite or overeating
  • Insomnia or hypersomnia
  • Low energy or fatigue
  • Low self-esteem
  • Poor concentration or difficulty making decisions
  • Hopelessness

During the 2-year period (1 year for children or adolescents) of the disturbance, the person has never been without the symptoms in Criteria A and B for more than 2 months at a time.

Criteria for a major depressive disorder may be continuously present for 2 years.

There has never been a manic episode, a mixed episode, or a hypomanic episode, and criteria have never been met for cyclothymic disorder.

The disturbance is not better explained by a persistent schizoaffective disorder, schizophrenia, delusional disorder, or other specified or unspecified schizophrenia spectrum and other psychotic disorder.

The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a general medical condition.

The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prognosis of PDD

A

~20% of patients with persistent depressive disorder go on to develop BPAD I or II

Poorer long-term outcome predicted by presence of:

  • Higher levels of neuroticism
  • Greater sx severity
  • Poorer global functioning
  • Presence of anxiety d/o or conduct d/o
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Diagnosis of Premenstrual Dysphoric Disorder

A

In the majority of menstrual cycles, at least 5 sxs must be present in the final week before onset of menses, start to improve within a few days after onset of menses, and become minimal or absent in the week postmenses.

One (or more) of the following must be present:

  • Affective lability (mood swings)
  • Irritability, anger, or increased interpersonal conflicts
  • Depressed mood, hopelessness, or self-deprecating thoughts
  • Anxiety, tension, and/or being “on edge”

One (or more) of the following must additionally be present, to reach a total of 5 sxs:

  • Decreased interest in usual activities
  • Subjective difficulty in concentration
  • Lethargy, easy fatigability, or marked lack of energy
  • Marked change in appetite; overeating; or specific food cravings
  • Hypersomnia or insomnia
  • A sense of being overwhelmed or out of control
  • Physical symptoms such as breast tenderness or swelling, joint or muscle pain, a sensation of “bloating,” or weight gain

***Symptom criteria must have been met for most menstrual cycles that occurred in the preceding year.

The symptoms are associated with clinically significant distress or interference with work, school, usual social activities, or relationships with others.

The disturbance is not merely an exacerbation of the symptoms of another disorder, such as major depressive disorder, panic disorder, persistent depressive disorder (dysthymia), or a personality disorder (although it may co-occur with any of these disorders).

Criterion A should be confirmed by prospective daily ratings during at least two symptomatic cycles.

The symptoms are not attributable to the physiological effects of a substance (e.g., a drug of abuse, a medication, other treatment) or another medical condition (e.g., hyperthyroidism).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Statistics for and Prognosis of PMDD

A

12-month prevalence in U.S. is ~1.8% of menstruating women

Risk factors for development:

  • High stress
  • Interpersonal trauma
  • Seasonal mood changes
  • Heritability

Sxs can start any time after menarche, and may worsen as menopause approaches

Sxs can be reduced with OCPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of depressive disorders

A

The successful treatment of a mood disorder begins with a careful diagnostic, psychosocial and medical evaluation.

  • Rule-out medical conditions
  • Rule-out substance abuse
  • Rule-out effects of medications
  • Rule-out other affective or psychiatric disorders – Bipolar disorder, anxiety, psychosis
17
Q

Physical treatments

A

Anti-depressant medication

  • SSRIs
  • SNRIs
  • MAOIs
  • TCAs
  • others –> bupropion, mirtazapine, trazadone
18
Q

Psychotherapy

A

A number of psychotherapies have been found to be as effective as antidepressants.

Two psychotherapies designed specifically for major depression – interpersonal psychotherapy and cognitive therapy - have been proven effective in controlled studies.

Psychodynamic
Cognitive
Interpersonal
Behavioral
EMDR
Solution-focused
19
Q

Brain stimulation - electroconvulsive therapy

A
  • ECT is the oldest and most reliable of the modern somatic therapies for mood disorders, with a remission rate in major depression upwards of 80-90%.
  • ECT is usually recommended for depressed patients who are refractory to antidepressants.
  • In ECT an electrical stimulus is applied for two milliseconds through right (nondominant) unilateral (RUL) electrodes or bilaterally –> A seizure is produced which lasts 20 – 150 seconds.
  • In routine use, RUL ECT is used first because it is associated with a lower risk of cognitive impairment.
  • Bifrontal or bitemporal placement of leads is also possible.
  • Bilateral ECT is used for nonresponsive to unilateral ECT and as an initial approach in severe depression, psychotic depression, catatonic stupor, and depression in which fewer treatments are desirable.
  • The most common side effects of ECT are confusion and memory loss.
  • These effects are more pronounced after bilateral ECT.
  • Anterograde amnesia is most common within 45 minutes of a treatment.
  • Most of the time cognitive function after recovery from the acute effects of ECT is better, probably because of cognitive improvement from the depression.
20
Q

Vagal stimulation

A

Used in treatment-refractory patients (no response to trials of ≥ 4 antidepressants.

  • Implantation in outpatient setting, under general anesthesia.
  • The procedure takes ~ 1 hour.
  • Pacemaker-like device is implanted in the L chest wall + leads wrapped around the vagus nerve in L neck.
  • The pacemaker-like pulse generator delivers pulses to the vagus nerve, usually for 30 seconds every five minutes, 24-hours per day.
  • Improves depression by increased neurotransmitter output (serotonin, NE, dopamine) which boosts patient response to existing antidepressant medications.
  • Onset of action is several weeks.

Side effects include:

  • Complication from implantation procedure (1-4% rate of infection)
  • Hoarseness (from the spread of electrical stimulation in the neck to the vocal cords)
21
Q

Transcranial magnetic stimulation

A

Approved for use in 2008 to treat MDD in patients who have failed at least one antidepressant trial.

  • A current placed on the scalp generates a magnetic field, which induces electrical current in the underlying dorsolateral prefrontal cortex to depolarize cortical neurons and stimulate nerve impulses.
  • The patient is awake during the treatment and generally experiences tapping or knocking sensations.
  • The primary side effect from the procedure is headache.

Treatment plan: rTMS 5 days a week x 4-6 weeks

  • Each treatment delivers 3,000 magnetic pulses over ~38 minutes through a coil held to the patient’s scalp.
  • Recent studies show about 50% remission rate of depression (less than ECT!) with few side effects.